Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo

Clin Exp Dermatol. 2017 Dec;42(8):942-944. doi: 10.1111/ced.13290. Epub 2017 Oct 16.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alopecia Areata / drug therapy*
  • Alopecia Areata / immunology
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / immunology
  • Humans
  • Janus Kinase Inhibitors / pharmacology
  • Male
  • Piperidines / administration & dosage
  • Piperidines / adverse effects
  • Piperidines / pharmacology*
  • Piperidines / therapeutic use
  • Protein Kinase Inhibitors / pharmacology
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects
  • Pyrimidines / pharmacology*
  • Pyrimidines / therapeutic use
  • Pyrroles / administration & dosage
  • Pyrroles / adverse effects
  • Pyrroles / pharmacology*
  • Pyrroles / therapeutic use
  • Th2 Cells / drug effects
  • Th2 Cells / immunology
  • Treatment Outcome
  • Vitiligo / drug therapy*
  • Vitiligo / immunology

Substances

  • Janus Kinase Inhibitors
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles
  • tofacitinib